RelayPro Thoracic Stent-Graft System
Bolton Medical, Inc. · Decision date Aug 5, 2021
What did the FDA approve?
The FDA database records an August 5, 2021 approval for the RelayPro Thoracic Stent-Graft System from Bolton Medical, Inc. The stated indication covers endovascular repair of fusiform aneurysms and saccular aneurysms or penetrating atherosclerotic ulcers in the descending thoracic aorta for patients with specified anatomy. Those anatomic criteria include iliac or femoral access vessel morphology compatible with vascular access techniques, devices, or accessories, and a non-aneurysmal aortic neck diameter of 20 to 42 mm.
The approval statement lists required non-aneurysmal proximal aortic neck lengths by device configuration and diameter. Bare Stent Configuration lengths range from 15 mm for 24 to 28 mm diameters to 25 mm for 40 to 46 mm diameters. Non-Bare Stent Configuration lengths are 25 mm for 24 to 38 mm diameters and 30 mm for 40 to 46 mm diameters. Distal aortic neck lengths are 25 mm for 24 to 38 mm device diameters and 30 mm for 40 to 46 mm device diameters. The record does not state clinical outcomes or comparative effectiveness.
FDA approval order statement
Approval for The RelayPro Thoracic Stent-Graft System. The device is indicated for the endovascular repair of fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers in the descending thoracic aorta in patients having appropriate anatomy, including:-- Iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories;-- Non-aneurysmal aortic neck diameter in the range of 20 to 42 mm; and -- Non-aneurysmal proximal aortic neck lengths of: 15 mm for the 24 to 28 mm Bare Stent Configuration device diameters 20 mm for the 30 to 38 mm Bare Stent Configuration device diameters 25 mm for the 40 to 46 mm Bare Stent Configuration device diameters 25 mm for the 24 to 38 mm Non-Bare Stent Configuration device diameters 30 mm for the 40 to 46 mm Non-Bare Stent Configuration device diameters Non-aneurysmal distal aortic neck lengths of: 25 mm for the 24 to 38 mm device diameters 30 mm for the 40 to 46 mm device diameters.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 5, 2021
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P200045
- Regulatory pathway
- Premarket approval application
- Applicant
- Bolton Medical, Inc.
- Product code
- MIH
- Decision code
- APPR
- Decision date
- Aug 5, 2021
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.
- Applicant
- Bolton Medical, Inc.
- Product code
- MIH
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P200045 received
Application receipt date recorded by FDA.
P200045 · FDA decision
APPR
P200045/S025 · Related supplement
RelayPro Thoracic Stent-Graft Delivery System
Timeline entries are records held by MedtechLedger for P200045. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200045
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
RelayPro Thoracic Stent-Graft Delivery SystemP200045/S025 | Bolton Medical, Inc. | PMA supplement | Oct 28, 2026 | FDA |
Explore the linked device profile
Other records with product code MIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook, Inc. | PMA supplement | Sep 17, 2026 | FDA | |
| Cook, Inc. | PMA approval | May 23, 2003 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bolton Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 799 International Pkwy., Sunrise, FL, 33325
Sources and methodology
- Original FDA record: P200045
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

